Modest SG&A growth and the lapping of 100th-anniversary expenses
First written in FY2017-Q3. 8 of 30 entries say "Worsened", first in FY2019-Q1. Latest entry: FY2026-H1.
Nagaileben moved to the "Worse" side of this theme in 2023.
0 other companies' latest entry also says "Worsened".
- FY2026-H1WorsenedAnnual report
「SG&A expenses increased 6.1% year on year due to higher personnel expenses resulting from wage increases and other factors.」
Higher personnel expenses resulting from wage increases and other factors led to a 6.1% year-on-year increase in SG&A expenses. - FY2025-H1ReframedAnnual report
「Selling, general and administrative expenses increased 2.0% year on year due mainly to higher personnel costs resulting from wage increases, intensified mid-career recruitment and other factors.」
The drivers of higher SG&A expenses have shifted from one-off expenses in prior years and the recovery in sales activities to higher personnel expenses resulting from wage increases and increased mid-career hiring. - FY2024The annual growth rate decreasedAnnual report
「SG&A expenses were ¥3,024 million, up 2.8% year on year.」
SG&A expenses increased 2.8% year on year, slowing from the 3.2% increase in the previous fiscal year. The increase was driven by higher personnel expenses resulting from wage increases and other factors. - FY2024-Q3WorsenedAnnual report
「SG&A expenses increased 4.2% year on year due to higher personnel expenses resulting from wage increases and other factors.」
SG&A expenses increased 4.2% year on year against a backdrop of higher personnel expenses resulting from wage increases and other factors, with the increase widening from 2.7% in the previous quarter. - FY2024-Q2MitigatedAnnual report
「Selling, general and administrative expenses increased 2.7% year on year due mainly to higher personnel costs resulting from wage increases and other factors, but were 3.1% below plan.」
SG&A expenses increased year on year due to wage increases and other factors, but the growth rate was below the 6.1% increase in the same period of the previous year and was 3.1% below plan. - FY2024-Q1WorsenedAnnual report
「SG&A expenses increased 7.7% year on year as restrictions on visits to medical institutions were eased and sales activities recovered in Japan and overseas, driving increases in travel expenses, transportation costs, advertising and promotion expenses, and other items.」
Travel expenses, transportation costs, advertising and promotion expenses, and other costs increased as restrictions on visits to medical institutions were eased and sales activities recovered, resulting in a 7.7% year-on-year increase in SG&A expenses. - FY2023WorsenedAnnual report
「SG&A expenses were ¥2,942 million, up 3.2% year on year. The main factor was an increase in travel expenses, transportation costs and trade show expenses as restrictions on visits to medical institutions were eased and sales activities recovered in Japan and overseas, resulting in a 3.2% year-on-year increase.」
SG&A expenses increased 3.2% year on year as sales activities and trade shows recovered. - FY2023-Q3SG&A expenses increased year on yearAnnual report
「SG&A expenses increased 4.2% year on year as restrictions on visits to medical institutions were eased and sales activities recovered in Japan and overseas, driving increases in travel expenses, transportation costs and trade show expenses.」
Travel expenses, transportation costs and trade show expenses increased as restrictions on visits to medical institutions were eased and sales activities recovered, resulting in a 4.2% year-on-year increase in SG&A expenses. - FY2023-Q2WorsenedAnnual report
「SG&A expenses increased 6.1% year on year as restrictions on visits to medical institutions were eased and sales activities recovered in Japan and overseas, driving increases in travel expenses, transportation costs and trade show expenses, but were 4.1% below plan.」
Travel expenses, transportation costs and trade show expenses increased as sales activities recovered, resulting in a 6.1% year-on-year increase in SG&A expenses. However, SG&A expenses were 4.1% below plan. - FY2023-Q1SG&A expenses increasedAnnual report
「SG&A expenses increased 2.7% year on year as restrictions on visits to medical institutions were eased and sales activities recovered in Japan and overseas, driving increases in travel expenses, transportation costs and trade show expenses.」
Travel expenses, transportation costs and trade show expenses increased as restrictions on visits to medical institutions were eased and sales activities recovered, resulting in a 2.7% year-on-year increase in SG&A expenses. - FY2022SG&A expenses edged upAnnual report
「SG&A expenses were ¥2,850 million, up 0.1% year on year. The main factor was an increase in travel expenses and transportation costs as restrictions on visits to medical institutions were eased and sales activities recovered in Japan and overseas, resulting in a 0.1% year-on-year increase.」
SG&A expenses turned to a 0.1% year-on-year increase as restrictions on visits to medical institutions were eased and sales activities recovered, reversing the declining trend caused by restrictions on sales activities during the pandemic. - FY2022-Q3SG&A expenses decreased year on yearAnnual report
「SG&A expenses decreased 0.3% year on year. In connection with COVID-19, travel expenses and transportation costs began to increase as restrictions on visits to medical institutions were eased and sales activities recovered in Japan and overseas, but advertising and promotion expenses declined due to the postponement or cancellation of trade shows.」
While travel expenses and transportation costs began to increase as sales activities recovered, lower advertising and promotion expenses resulting from the postponement or cancellation of trade shows led to a 0.3% year-on-year decrease in SG&A expenses. - FY2022-Q2SG&A expenses increased year on yearAnnual report
「As restrictions on visits to medical institutions were eased in connection with COVID-19 and sales activities recovered in Japan and overseas, travel expenses and transportation costs increased, resulting in a 0.9% year-on-year increase.」
SG&A expenses increased 0.9% year on year as restrictions on visits to medical institutions were eased and sales activities recovered in Japan and overseas, marking a shift from the previous declining trend to growth. - FY2022-Q1SG&A expenses decreased year on yearAnnual report
「SG&A expenses decreased 2.4% year on year due to lower advertising and promotion expenses resulting from the postponement or cancellation of trade shows in connection with COVID-19.」
SG&A expenses decreased 2.4% year on year due to lower advertising and promotion expenses resulting from the postponement or cancellation of trade shows. - FY2021SG&A expenses decreased year on yearAnnual report
「SG&A expenses were ¥2,846 million, down 0.9% year on year. In connection with COVID-19, restrictions on domestic and international travel and the postponement or cancellation of trade shows reduced advertising and promotion expenses, travel expenses and transportation costs, resulting in a 0.9% year-on-year decrease.」
Advertising and promotion expenses, travel expenses and transportation costs decreased due to restrictions on domestic and international travel and the postponement or cancellation of trade shows, resulting in a 0.9% year-on-year decrease in full-year SG&A expenses. - FY2021-Q3SG&A expenses decreased year on yearAnnual report
「SG&A expenses decreased 2.7% year on year as the company continued to refrain from conventional sales activities and take other measures to prevent the spread of COVID-19.」
SG&A expenses decreased 2.7% year on year due to restrictions on sales activities and other measures to prevent the spread of COVID-19. - FY2021-Q2SG&A expenses decreased year on yearAnnual report
「SG&A expenses decreased 5.3% year on year due to restrictions on domestic and international travel and the postponement or cancellation of trade shows in connection with COVID-19.」
SG&A expenses decreased 5.3% year on year due to restrictions on domestic and international travel and the postponement or cancellation of trade shows. - FY2021-Q1SG&A expenses decreased year on yearAnnual report
「SG&A expenses decreased 4.9% year on year due to restrictions on domestic and international travel and the postponement or cancellation of trade shows in connection with COVID-19.」
SG&A expenses decreased 4.9% year on year due to restrictions on domestic and international travel and the postponement or cancellation of trade shows. - FY2020RestatedAnnual report
「SG&A expenses were ¥2,872 million, down 1.7% year on year.」
SG&A expenses decreased 1.7% year on year, mainly due to the reversal of the one-off expenses associated with the abolition of the executive retirement bonus system in the previous year. - FY2020-Q3MitigatedAnnual report
「SG&A expenses decreased 1.1% year on year, despite costs arising from donations of masks and isolation gowns to medical institutions and other recipients as part of the company's social contribution activities to combat COVID-19, because one-off expenses such as the special payment associated with the abolition of the executive retirement bonus system decreased from the same period of the previous year.」
While costs arose from donations of masks and isolation gowns, one-off expenses associated with the abolition of the executive retirement bonus system decreased from the same period of the previous year, resulting in a 1.1% year-on-year decrease in SG&A expenses. - FY2020-Q2MitigatedAnnual report
「In the same period of the previous year, SG&A expenses included one-off factors such as the special payment associated with the abolition of the executive retirement bonus system. As no such one-off factor arose in the cumulative second quarter of the current fiscal year, SG&A expenses decreased 3.3% year on year.」
As the one-off expense associated with the abolition of the executive retirement bonus system that arose in the same period of the previous year did not arise in the current period, SG&A expenses decreased 3.3% year on year. - FY2020-Q1MitigatedAnnual report
「In the same period of the previous year, SG&A expenses included the special payment associated with the abolition of the executive retirement bonus system as a one-off expense. As no such one-off factor arose in the cumulative first quarter of the current fiscal year, SG&A expenses decreased 9.7% year on year.」
As the one-off expense associated with the abolition of the executive retirement bonus system that arose in the same period of the previous year did not arise in the current quarter, SG&A expenses decreased 9.7% year on year. - FY2019WorsenedAnnual report
「SG&A expenses were ¥2,922 million, up 4.9% year on year. The main factor was the ¥81 million increase in special payments associated with the abolition of the executive retirement bonus system, a one-off factor in the current period.」
Full-year SG&A expenses increased 4.9% year on year, mainly due to the ¥81 million special payment associated with the abolition of the executive retirement bonus system. - FY2019-Q3RestatedAnnual report
「SG&A expenses increased 2.0% year on year, but ¥81 million in special payments related to the abolition of the retirement benefit system for directors and corporate auditors, an exceptional factor in the current period, was incurred, bringing SG&A expenses to ¥2,240 million, up 5.9% year on year.」
The ¥81 million special payment associated with the abolition of the executive retirement bonus system continues to push up SG&A expenses as a one-off factor. - FY2019-Q2WorsenedAnnual report
「SG&A expenses increased by ¥6 million due to higher domestic transportation costs following freight rate increases, while ¥81 million in special payments related to the abolition of the retirement benefit system for directors and corporate auditors was incurred, bringing SG&A expenses to ¥1,576 million, up 7.7% year on year. (Excluding the exceptional factors in the current period, SG&A expenses increased 2.1% year on year.)」
In addition to higher domestic transportation costs due to freight rate increases, ¥81 million in special payments related to the abolition of the retirement benefit system for directors and corporate auditors was incurred, resulting in a 7.7% year-on-year increase in SG&A expenses. - FY2019-Q1WorsenedAnnual report
「SG&A expenses amounted to ¥735 million, up 15.1% year on year. The main factor behind the increase was ¥81 million in one-time expenses, including special payments related to the abolition of the retirement benefit system for directors and corporate auditors.」
SG&A expenses increased 15.1% year on year, mainly due to ¥81 million in one-time expenses related to the abolition of the retirement benefit system for directors and corporate auditors. - FY2018AdvancedAnnual report
「SG&A expenses amounted to ¥2,786 million, down 2.0% year on year. The main factors behind the decrease were lower depreciation and cost reductions from improved operational efficiency.」
Following a 0.5% year-on-year increase in SG&A expenses in the third quarter of the previous fiscal year and a 2.1% full-year increase, SG&A expenses decreased 2.0% in the current fiscal year, mainly due to lower depreciation and improved operational efficiency. - FY2018-Q3SG&A expenses decreased year on yearAnnual report
「Selling, general and administrative expenses 2,119,440 2,116,280」
SG&A expenses decreased from ¥2,119 million in the same period of the previous year to ¥2,116 million in the current period. - FY2017ReframedAnnual report
「SG&A expenses amounted to ¥2,843 million, up 2.1% year on year. The main factor behind the increase was enterprise-size-based taxation.」
Full-year SG&A expenses increased 2.1% year on year, with the increase attributed to enterprise-size-based taxation. The absence of the 100th-anniversary commemorative expenses mentioned in the previous quarter was not explicitly noted in this full-year explanation. - FY2017-Q3First statedAnnual report
「SG&A expenses increased 0.5% year on year to ¥2,119 million in the nine months ended Q3, despite an increase in enterprise-size-based taxation. The nine months ended Q3 of the previous fiscal year included one-time expenses for the company's 100th anniversary.」
Although enterprise-size-based taxation increased, SG&A expenses rose only 0.5% year on year. The comparison also reflects the one-time 100th-anniversary commemorative expenses included in the same period of the previous year.